Advertisement
High versus low intake of coffee is associated with a reduced risk for endometrial cancer

High Coffee Intake Linked With Lower Risk of Endometrial Cancer

0
Women benefited from drinking about four cups daily
Motivational interviewing can be a useful approach for reaching noncompliant patients

Motivational Interviewing Can Help Reach Nonadherent Patients

0
Although working with patients to set personal goals may take more time, the investment pays off
Soy food/isoflavone intake is not associated with endometrial cancer risk in Japanese women

Soy Food, Isoflavone Intake Not Linked to Endometrial Cancer

0
Findings in Japanese women aged 45 to 74 years followed during average of 12.1 years
Meaning-centered group psychotherapy is effective for reducing psychological distress and improving spiritual well-being in patients with advanced cancer

Meaning-Centered Group Therapy Beneficial in Advanced Cancer

0
Improvements in patient quality of life, reduction in psychological distress
The tragic shooting of surgeon Michael Davidson can be used as an opportunity to find meaning in tragedy

Perspective on Dr. Davidson: ‘Be Like Mike’

0
Michael Davidson took on highest risk patients, sought to extend lives in cases deemed 'hopeless'
Scientists say they have identified two new genetic variants that are associated with an increased risk of breast cancer. Their findings are published online Feb. 4 in Human Molecular Genetics.

Two Novel Genetic Variants for Breast Cancer Discovered

0
London scientists say variants most strongly linked to estrogen receptor-positive disease
Fewer than half of Americans are aware that some major lifestyle factors can affect their cancer risk

AICR: Awareness of Key Cancer Risk Factors Alarmingly Low

0
Many worry about unproven factors like food additives; less about exercise and obesity
Lung cancer has overtaken breast cancer as the leading cancer killer of women in developed countries

Lung Cancer Now Leads Cancer Mortality in Developed Nations

0
Leading cancer killer of American women for many years
Ibrance (palbociclib) has been approved by the U.S. Food and Drug Administration to treat advanced breast cancer among postmenopausal women.

FDA Approves Ibrance to Treat Advanced Breast Cancer

0
For postmenopausal women with ER+, HER2− metastatic breast cancer
The 2014 recommendations for the prophylaxis and treatment of venous thromboembolism in patients with cancer are unchanged from 2013

Guidelines for VTE Prophylaxis, Treatment in Cancer Unchanged

0
Thromboprophylaxis required throughout hospitalization for most patients with active cancer